Table 1 Summary of clear cell adenocarcinoma of the peritoneum
From: Clear cell adenocarcinoma of the peritoneum: a case report and literature review
Case | Authors | Age | Tumor size and location | Past history or concurrent disease | Concurrent endometriosis | Treatment | Residual tumour | Outcome |
|---|---|---|---|---|---|---|---|---|
1 | Evans et al. [3] | 54 | 18×13 cm | Both Ov EM, AM, EH | Yes | DS followed by RT (pelvic; 4500R,upper abdomen;3000 R) | None | NA |
sigmoid mesocolon | ||||||||
2 | Lee et al. [4] | 67 | 6 cm | Concurrent EMA G1 of Ut (stageIb) | No | DS+TAH+BSO | >2 cm | NA |
Pelvic | ||||||||
3 | Tziortzioti et al. [5] | 62 | 0.5-2 cm | Concurrent CCC in EP | No | DS+TAH+BSO +OM followed by CHT (6 cycles, regimen NA) | >2 cm | DOD at 6 mo |
Peritoneal and omental | ||||||||
4 | Ichimura et al. [6] | 45 | NA | Both Ov EM | Yes | DS+TAH+BSO followed by CHT (3 cycles of CPA,CDDP, CBDCA) | None | ROD at 32 mo |
Pelvic | ||||||||
5 | Hama et al. [7] | 53 | NA | EM | Yes | DS+BSO followed by CHT (regimen NA) | >2 cm | DOD at 5 mo |
Ascites and small peritoneal solid lesions | ||||||||
6 | Terada et al. [8] | 49 | 3 cm, 2 cm | Past EMA G3 of Ut (TAH+BSO) | No | DS | None | NED at 6 mo |
Gastric peritoneal, splenic hilus | ||||||||
7 | Takano et al. [9] | 53 | 5 cm | None | No | DS followed by CHT (1 cycle of CPT-11,CDDP, 1 cycle of TC) | >2 cm | DOD at 5 mo |
Upper abdomen between liver and diaphragm and omentum | ||||||||
8 | Takano et al. [9] | 66 | 15×20 cm | None | No | DS+TAH+BSO+OM+PLD+PAD followed by CHT (6 cycles of CPT-11, CDDP) | None | NED at 20 mo |
Infracolic omentum and peritoneum of right abdominal wall | ||||||||
9 | Matsuo et al. [10] | 37 | 14×13 cm | EM | Yes | DS followed by CHT (6 cycles of TC), Secondary devulking surgery | None | ROD at 18 mo |
Abdominal scar of EM surgery | ||||||||
10 | Muezzinoglu et al. [11] | 54 | 25 cm | Peritoneal EM | Yes | DS+TAH+BSO following by CHT (regimen NA) | None | NED at 12 mo |
Abdominal | ||||||||
11 | Johnson et al. [12] | 54 | 5.6×3.7×3.5 cm | 3xMMs, TAH+BSO for LM and menorrhagia | No | CHT (6 cycles of TC) followed by EBR followed by the interstitial HDR BT boost | <2 cm | ROD at 4 mo |
proximal vagina and vaginal cuff | ||||||||
12 | This report | 59 | 7 cm | AM, EM | Yes | DS+TAH+BSO+PLD followed by CHT (6 cycles of TC) | None | NED at 5 mo |
Pelvic (pouch of douglas) |